Abbott Laboratories (ABT) Change in Inventory (2009 - 2026)

Abbott Laboratories has disclosed Change in Inventory across 18 years of filings, most recently posting $301.0 million for Q2 2026.

• In Q2 2026, Change in Inventory rose 10133.33% year-over-year to $301.0 million; the TTM figure through Jun 2026 stood at $274.0 million (up 234.98% YoY), while the FY2025 annual figure was -$195.0 million, down 436.21% from the prior year.
• Change in Inventory came in at $301.0 million for Q2 2026 at Abbott Laboratories, down from $420.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $554.0 million in Q1 2022 to a low of -$295.0 million in Q4 2023.
• Average Change in Inventory over 5 years is $123.8 million, with a median of $191.5 million recorded in 2022.
• Year-over-year, Change in Inventory tumbled 256.08% in 2023 and surged 10133.33% in 2026.
• Over 5 years, Change in Inventory stood at $189.0 million in 2022, then plunged by 256.08% to -$295.0 million in 2023, then advanced by 20.34% to -$235.0 million in 2024, then increased by 0.43% to -$234.0 million in 2025, then jumped by 228.63% to $301.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $301.0 million in Q2 2026, $420.0 million in Q1 2026, and -$234.0 million in Q4 2025.